On Thursday, United States regulators approved the first drug destined to allow people deal with chronic migraines a lot easier. Thanks to the Food and Drug Administration’s new action, the monthly shot called Aimovig is available for sale. This is actually the first one in a new class of chronic migraine drugs, and three other such shots are anticipated to win approval next year. Moreover, several other drugs for migraines are currently being tested. There are some prevention treatments available now, but most of them derive from pills originally destined for epilepsy. Then there is also Botox, the famous wrinkle reducer.
However, most people abandon these treatments because most of them do not change anything when it comes to chronic migraines. Apart from this, some of them also cause serious side effects that people would much rather avoid. The drug called Aimovig needs to be injected under the skin every month using a device that looks like a pen. Its price without insurance will be of $6,900 per year.
Chronic migraine prevention drug approved by the FDA
Official numbers are saying that about 10 million Americans get chronic migraines frequently. People who are in their 30s and women are the most affected by them. Chronic migraines cause some severe symptoms which include, apart from the strong headaches, vomiting, nausea, blurry vision and sensitivity to sound and light. Chronic migraines can sometimes last up to a few hours and in extreme cases, even for entire days. They are debilitating and unbearable for certain people.
In an experiment involving Aimovig, the number of migraines of some patients was cut from eight to just four in one month. There were also some minor side effects, like respiratory infections and colds, but they were nothing compared to the side effects of previous treatments. At the same time, some patients completely got rid of migraines after taking Aimovig.
Image source: flickr